Presentation on theme: "Muhammad Fahad Khan Muhammad Ali Khan"— Presentation transcript:
1 Muhammad Fahad Khan Muhammad Ali Khan POST CABG ATRIAL FIBRILLATION/FLUTTER; IDENTIFICATION OF THE HIGH RISK PATIENTS AND THE EFFECTIVENESS OF PROPHYLACTIC BETA BLOCKER THERAPY IN A COMMUNITY HOSPITAL SETTINGMuhammad Fahad KhanMuhammad Ali Khan
2 BackgroundAtrial fibrillation (AF) is the most common complication of coronary artery bypass grafting (CABG) with or without valvular surgery.AF has been reported in up to 40 percent of patients in the post-operative period.Most cases of AF occur between 24 to 48 hours after the surgery.Maisel, WH, Rawn, JD, Stevenson, WG. Atrial fibrillation after cardiac surgery. Ann Intern Med 2001; 135:1061.Mathew, JP, Fontes, ML, Tudor, IC, et al.A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004; 291:1720.Villareal, RP, Hariharan, R, Liu, BC, et al.Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol 2004; 43:742.
3 BackgroundAF contributes significantly to morbidity, cost and length of stay associated with this procedure.Postoperative AF may also identify a subset of patients with increased in-hospital and long-term mortality.A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004; 291:1720.Villareal, RP, Hariharan, R, Liu, BC, et al.Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol 2004; 43:742.
4 The ACC/AHA guidelines ACC/AHA strongly recommends prophylactic therapy for the prevention of post CABG AF especially for high risk patients.Recommend preoperative or postoperative oral BB (beta blocker) therapy for the prevention of post CABG AF (Class 1B).Other recommended pharmacological prophylactic therapies include Sotalol (Class 1C) and Amiodarone (Class 1C).ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary
5 Purpose of StudyTo evaluate the predictability of this arrhythmia using previously identified risk factors.To assess the efficacy of recommended prophylactic therapy (beta blockers) in a community hospital setting.
6 MethodologyThis is a retrospective chart review study of consecutive patients undergoing CABG with or without valvular surgery during 1 year period at SBMH.The protocol was approved by SBMH IRB committee.Patient Consent was waived being a retrospective chart review study.
7 DefinitionAtrial fibrillation was defined as irregular QRS complex without identifiable P waves.All patients were monitored using 24 hour telemetery.Atrial fibrillation was diagnosed on the review of EKG and telemetry strips and confirmed with physician’s notes.Post operative period was defined as the time spent in the hospital after the surgery.
8 Inclusion CriteriaAll the patients who had CABG (off-pump or on-pump) with or with valvular surgery between 1/1/06 and 12/31/06 at SBMH were included in the study.All the patients who had valvular surgery alone between 1/1/06 and 12/31/06 at SBMH were also included.
9 Exclusion CriteriaPatients who underwent open heart surgery other than CABG and valvular surgery.Patient who already had atrial fibrillation/flutter or other arrhythmia at the time they entered the surgery.
10 MethodologyPatients who developed new onset AF for more than one hour in duration after the surgery were designated as cases and those who did not, as controls.We compared 67 different preoperative, intraoperative and postoperative variables between these two groups.These variables were derived from the previous studies with similar objectives.
11 Abbreviations used BB Beta Blocker NS BB Non Specific Beta Blocker AF AtrialFibrillationMPL MetoprololATL AtenololPPL PropranololCRG CarvedilolARR Absolute risk reductionRR Relative RiskRCT RandomizedControl TrialLA Left AtriumPO OralIV IntravenousHTN HypertensionT Total
12 Total patients 247 13 patients excluded 231 53 patients AF 3 patients isolatedAVR/MVR13 patients excludedArrhythmia23153 patientsAF178 patientsNo AF
13 Statistical AnalysisCategorical variables were analyzed using Chi-square test.Whereas continuous variables were analyzed using independent sample t-test.Statistical significance was defined as p<0.05.All the statistical analysis was carried out using SPSS. (Chicago, Ill. version 17).
14 Statistical AnalysisMultivariate analysis was carried out using Logistic regression model to find out independent correlation between different variables and the development of post CABG AF.
17 Results53 of 231 (23%) patients undergoing CABG with or without valvular surgery developed AF during post-operative period.Cases were older than controls (mean age 72 vs. 64, p< 0.01).On bivariate analysis, multiple factors were found to predispose to the development of AF.
18 Effectiveness of BB therapy In terms of prophylactic therapy, 35 of 53 (66%) cases were taking BB as compared to 87 of 178 (48%) of controls (p=0.02).But on multivariate analysis only Age (p=0.002) and BNP (p=0.019) were found to be independent predictors for the development of post CABG AF.
19 Effectiveness of BB therapy VariableOn BB(122)Not on BB(109)P valueAge (mean)67.34 ± 10.664.3 ± 12.20.041Abnormal BNP750.77Abnormal EF16200.28AF at disharge1360.23Post op AF35180.029AVR1Statin91410.00h/o AF2h/o CHFh/o/ CAD600.008h/o COPD1110h/o DM46240.1Dyslipidemia9763HTN10564Sex (male)7881
20 ConclusionWe concluded that advanced age, history of AF, enlarged left atrial size, history of CHF and elevated BNP levels as predictors for the development of post CABG AF.In terms of prophylactic beta blocker therapy, 35 of 122 (28.6%) developed AF while on beta blocker whereas only 18 of 109 (16.5%) developed AF in the absence of prophylactic beta blockers. However, on multivariate analysis, this predisposing effect was not significant.Based on this analysis, BB did not show protection against post CABG AF.
21 Limitations Retrospective chart review analysis. The patient population is small.Belongs to a single community hospital thus the data and results derived may not be generalized to reflect other cardiac surgery centers.
22 Possible reasons for BB ineffectiveness Decreased oral bioavailability of these drugs during perioperative period ?Is there any difference among different class of BB ?IV BB better than oral BB?
23 Decreased Metoprolol bioavailability Valtola A, Kokki H, Gergov M, Ojanperä I, Ranta VP, Hakala T. Eur J Clin Pharmacol May;63(5): Epub 2007 Feb 28.
24 HypothesesIf blood levels of oral MPL are lowest on first postoperative day, then it should create an effect similar to BB withdrawal. (BB withdrawal has been shown to predispose to the development of Post CABG AF).Prophylactic BB started on postoperative period should prevent AF better than preoperative BB due to lack of this withdrawal.As there will be no withdrawal due to IV BB, they should show better protection for post CABG AF.As pharmacokinetics varies among different BB, there should difference among different drugs as far as the prevention is concerned.Budeus M, Feindt P, Gams E, Wieneke H, Sack S, Erbel R, Perings C. Ann Thorac Surg Jul;84(1):61-6.
25 AnalysisWe retrospectively reviewed 231 charts (same study population), to find out the timing, route and type of prophylactic BB.In our setting most of the patients were given Metoprolol.All the patients were given prophylactic BB orally.Major contraindications to BB included bronchospasm, hypotension and AV blocks.
26 Effectiveness of BB therapy VariablePostoperative BB(101)Preoperative BB(119)P valueAge (mean)64.0 ± 12.467.2 ± 10.70.05Abnormal BNP560.9Abnormal EF20150.14AF disharge120.16Post op AF1733AVR0.8Statin36880.00h/o CABG4h/o AF20.001h/o CHF0.77h/o/ CAD31580.006h/o COPD8110.7h/o DM23450.016Dyslipidemia94HTN60101Sex (male)74760.13Abnormal LA size0.27
27 ResultsThere is statistically significant difference between two groups in terms of post CABG AF.But two groups are also different in terms of various variables like age, preoperative medications, h/o AF, CAD and DM.Partially proves the BB withdrawal hypothesis.Again limited retrospective study.
28 POOLED ANALYSISWe preferred pooled analysis over the meta-analysis to reveal even a smaller yet clinically significant difference.We searched the MEDLINE data base using the words, “BB”, “Post CABG arrhythmias”, “Prophylaxis of Post CABG AF”, “Randomized prospective trial”.We limited our search to 1990 till present due recent changes in the techniques and protocols of CABG.Initially 26 trials were selected but 7 were excluded due to various reasons.
29 Characteristics of the trials Trails were carefully reviewed by two independent reviewers with particular attention to inclusion criteria, method of randomization, exact timing of administration of postoperative BB, definition of atrial fibrillation, continuity of telemetry during postoperative period and the duration of follow up.In all trials, patients with low EF < 40%, severe COPD and AV blocks were excluded.
30 Initial trials selected 263 trials non RCT3 Trials NS BBCombination of BBused19 trialsTotal patients2011AF patients416
31 Characteristics of the trials All the studies can be combined as they used similar patient inclusion/exclusion criteria, similar drug and control groups, similar definition of AF and a common primary end point i.e., the development of post CABG AF.Patient groups were not significantly different regarding various pre, intra and postoperative variables.
32 Pooled analysis- Results DrugsPostopPeropAF (post)AF (pre)ARRRRP valueMPL(PO)963156247(25.6%)43(27.5%)2%0.930.61MPL(IV)120-----20(16.66%)------10%0.640.031MPL(T)1083267(24.6%)3%0.890.43CRG(PO)11518(15.6%)0.600.018PPL(PO)10918(16.5%)9%0.036PPL(IV)12330(24.39%)8% INC.1.460.137PPL(T)23248(20.68%)4%0.830.199ATL(PO)19340(20.7%)7.5%0.750.136P value calculated by chi-squire method.Pre op BB- 349 total, 83 AF. Post op BB1419 total 283 AF, p value= 0.112DrugsPostopPeropAF (post)AF (pre)ARRRRP valueMPL(PO)963156247(25.6%)43(27.5%)2%0.930.61MPL(IV)120-----20(16.66%)------10%0.640.031MPL(T)1083267(24.6%)3%0.890.43CRG(PO)11518(15.6%)0.600.018PPL(PO)10918(16.5%)9%0.036PPL(IV)12330(24.39%)8% INC.1.460.137PPL(T)23248(20.68%)4%0.830.199ATL(PO)19340(20.7%)7.5%0.750.136P value calculated by chi-squire method.Pre op BB349 total 83 AF, Post op BB1419 total 283 AF, p value= 0.112P value calculated by chi-squire method.Pre op BB349 total 83 AF, Post op BB1419 total 283 AF, p value= 0.112
36 ResultsTotal number of patients given BB for the prevention of AF, including pre and post operative period were Of these 416 (23.6%) developed new onset post CABG AF.349 got BB in the preoperative period and 83 (23.78%) of them developed AF. All the preoperative BB were given orally.On other hand 1662 got postoperative BB for the prevention of AF. Of these patients 333 (20%) developed new onset AF.1419 patients were given oral BB while 243 were given IV BB during the postoperative period. 283 (20%) of oral group while 50 (20.5%) of the IV group developed post CABG AF.
37 Recommendations and conclusion BB differ significantly among themselves for their ability to prevent post CABG AF.There is also significant difference between oral and IV forms as well as timing of administration.Our analysis partially explains why BB are not fully effective for the prevention of post CABG AF.In our opinion further randomized control trials need to be done to evaluate the timing, route of administration and the type of beta blockers to prevent post CABG AF.
Your consent to our cookies if you continue to use this website.